Advances in endoscopic surgery for hepatocellular carcinoma

• Beppu Toru

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Horino Kei

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Komori Hiroyuki

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Masuda Toshiro

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Hayashi Hiromitu

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Okabe Hirohisa

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Okabe Kazutoshi

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Hayashi Naoko

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Takamori Hiroshi

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

• Baba Hideo

  Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University

抄録

Endoscopic microwave coagulation therapy (MCT) or radio-frequency ablation (RFA) was developed in 1994. 213 endoscopic ablations (37% of 570 ablations) and 40 endoscopic hepatectomies (12% of 328 hepatectomies) were performed in our department. Appropriate selection of thoraco- and laparoscopic approach, marginal pre-ablation method, pre-coagulation method using RFA, and laparoscopic hand-assisted approach are important points. To evaluate the efficacy of endoscopic surgery, the operative outcomes were compared to 86 patients who underwent open non-systematic partial hepatectomy, smaller than 4 cm, and up to three tumors, in the same period. In endoscopic ablation, endoscopic hepatectomy, and open hepatectomy, the percent of liver damage B/C, intraoperative blood loss, operating time, percent requiring blood product, postoperative hospital stay, 5-year cumulative survival rate and complication rate was 49%, 20%, 17%, 23g, 346g, 850g, 3.2 hrs, 5.2 hrs, 6.6 hrs, 1%, 12%, 21%, 8 days, 9 days, 18 days, 54%, 68%, 63%, and 8.2%, 6.7%, 12% respectively. No implantation of malignant cells was encountered in endoscopic surgery. Endoscopic surgery can become a new therapeutic modality in treatment strategy for HCC.

収録刊行物

• Ｊｏｕｒｎａｌ　ｏｆ　Ｍｉｃｒｏｗａｖｅ　Ｓｕｒｇｅｒｙ

  Ｊｏｕｒｎａｌ　ｏｆ　Ｍｉｃｒｏｗａｖｅ　Ｓｕｒｇｅｒｙ 26 67-72, 2008

  特定非営利活動法人 Microwave Surgery研究会

キーワード

• endoscopic surgery
• hepatocellular carcinoma
• radio-frequency ablation
• microwave coagulation therapy
• hepatic resection

詳細情報

• CRID: 1390282680156974720
• NII論文ID: 130000066639
• DOI: 10.3380/jmicrowavesurg.26.67
• ISSN: 1882210X
• ISSN: 09177728
• Web Site: https://search.jamas.or.jp/link/ui/2009120816
• 本文言語コード: en
• データソース種別:
  • JaLC
  • Crossref
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可